SG Americas Securities, LLC - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 88 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q1 2021. The put-call ratio across all filers is 0.04 and the average weighting 0.8%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2021$200,000
-33.6%
1,690
-33.7%
0.00%
-50.0%
Q4 2020$301,000
+119.7%
2,550
+106.6%
0.00%
+100.0%
Q3 2020$137,000
+37.0%
1,234
+26.0%
0.00%0.0%
Q2 2020$100,000
-9.9%
979
-4.4%
0.00%0.0%
Q1 2020$111,000
-39.0%
1,024
-34.4%
0.00%
-50.0%
Q4 2019$182,000
+5.2%
1,560
+3.3%
0.00%
+100.0%
Q3 2019$173,000
-7.5%
1,510
-23.2%
0.00%0.0%
Q2 2019$187,000
+59.8%
1,965
+32.6%
0.00%0.0%
Q4 2017$117,0001,4820.00%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q1 2021
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 131,657$13,077,0005.92%
Point72 Hong Kong Ltd 103,797$10,310,0003.49%
York Capital Management Global Advisors, LLC 827,738$82,219,0002.00%
Parametrica Management Ltd 3,889$386,0001.83%
Athos Capital Ltd 35,266$3,503,0001.19%
Hillhouse Capital Management 618,391$61,425,0001.05%
JUPITER ASSET MANAGEMENT LTD 502,812$49,940,0000.73%
Black Creek Investment Management Inc. 240,232$23,862,0000.73%
COMGEST GLOBAL INVESTORS S.A.S. 243,652$24,202,0000.54%
Temasek Holdings (Private) Ltd 990,000$98,337,0000.52%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders